Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Figs Inc (FIGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Figs Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $3.94B), while Figs Inc trades at $18.54 (market cap $2.99B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and Figs Inc is trading nearer its 52-week high, Edgewise Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Figs Inc for 31 Days on average.
| EWTX | FIGS | |
|---|---|---|
Market Cap | $3.94B | $2.99B |
Volume | 810,104 | 6,721,481 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $18.63 |
52-Week Low | $14.89 | $7.38 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $3.48B | $2.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FIGS trades at $18.00, up 1.35% with strong technical momentum and bullish moving average signals. The company shows accelerating revenue growth, improving margins, and consistent earnings beats, with Q2 2026 revenue surging 28.8% and international sales up 67%. Recent news highlights international expansion momentum and raised 2026 guidance.
The outlook remains positive with analyst consensus pointing to 26% upside potential, though premium valuation metrics require continued execution. Key risks include rich P/E ratio of 54.6 and execution challenges in maintaining growth momentum amid competitive retail landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →
